SEARCH RESULTS for ONCOMED PHARMACEUTICALS, INC.

Recent Patent Assignments Patent Assignments - (Total found: 15)

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
25-Jan-2018

(X0) 15636711: TNFRSF-BINDING AGENTS AND USES THEREOF

(A1) 20180021407: TNFRSF-BINDING AGENTS AND USES THEREOF

GURNEY, AUSTIN L.

ONCOMED PHARMACEUTICALS, INC.

43885/192

23-Jan-2018

(X0) 15210250: Methods for Identifying and Isolating Cells Expressing a Polypeptide

(A1) 20170002054: Methods for Identifying and Isolating Cells Expressing a Polypeptide

(B2) 9873726: Methods for Identifying and Isolating Cells Expressing a Polypeptide

GURNEY, AUSTIN L.

LAZETIC, ALEXANDRA L.L.

BOND, CHRISTOPHER J.

N/A

ONCOMED PHARMACEUTICALS, INC.

39880/195

26-Dec-2017

(X0) 11589993: Compositions and methods for diagnosing and treating cancer

(A1) 20070116701: Compositions and methods for diagnosing and treating cancer

(B2) 9850311: Compositions and methods for diagnosing and treating cancer

GURNEY, AUSTIN

LEWICKI, JOHN

SATYAL, SANJEEV

HOEY, TIMOTHY

N/A

ONCOMED PHARMACEUTICALS, INC.

18832/769

16-Nov-2017

(X0) 15439288: RSPO3 Binding Agents and Uses Thereof

(A1) 20170267776: RSPO3 Binding Agents and Uses Thereof

GURNEY, AUSTIN L.

BOND, CHRISTOPHER J.

ONCOMED PHARMACEUTICALS, INC.

44135/231

10-Nov-2017

(X0) 15506424: COMBINATION THERAPY FOR TREATMENT OF CANCER

(A1) 20170247465: COMBINATION THERAPY FOR TREATMENT OF CANCER

GURNEY, AUSTIN

YEN, WAN-CHING

ONCOMED PHARMACEUTICALS, INC.

44078/398

24-Oct-2017

(X0) 15406229: Wnt Antagonists and Methods of Treatment and Screening

(A1) 20170218041: Wnt Antagonists and Methods of Treatment and Screening

SATYAL, SANJEEV H.

MITRA, SATYAJIT SUJIT KUMAR

GURNEY, AUSTIN L.

ONCOMED PHARMACEUTICALS, INC.

43923/567

24-Oct-2017

(X0) 15401543: Modified Immunoglobulin Molecules That Specifically Bind Human VEGF and DLL4

(A1) 20170183406: Modified Immunoglobulin Molecules That Specifically Bind Human VEGF and DLL4

GURNEY, AUSTIN L.

SATO, AARON KEN

BOND, CHRISTOPHER JOHN

ONCOMED PHARMACEUTICALS, INC.

43923/940

19-Oct-2017

(X0) 15421635: Methods and Monitoring of Treatment With A DLL4 Antagonist

(A1) 20170299598: Methods and Monitoring of Treatment With A DLL4 Antagonist

BENNER, STEVEN EUGENE

STAGG, ROBERT JOSEPH

DUPONT, JAKOB

ONCOMED PHARMACEUTICALS, INC.

42933/181

19-Oct-2017

(X0) 15480081: RSPO BINDING AGENTS AND USES THEREOF

(A1) 20170298143: RSPO BINDING AGENTS AND USES THEREOF

GURNEY, AUSTIN L

AXELROD, FUMIKO TAKADA

HOEY, TIMOTHY CHARLES

CHARTIER-COURTAUD, CECILE

ONCOMED PHARMACEUTICALS, INC.

42934/222

19-Oct-2017

(X0) 15441700: Compositions and Methods for Treating and Diagnosing Cancer

(A1) 20170296658: Compositions and Methods for Treating and Diagnosing Cancer

GURNEY, AUSTIN

ONCOMED PHARMACEUTICALS, INC.

42934/338

06-Oct-2017

(X0) 15531876: Combination Therapy For Treatment of Cancer

(A1) 20170266276: Combination Therapy For Treatment of Cancer

GURNEY, AUSTIN

YEN, WAN-CHING

HOEY, TIMOTHY CHARLES

ONCOMED PHARMACEUTICALS, INC.

43789/35

29-Jun-2017

(X0) 15291334: NOTCH1 RECEPTOR BINDING AGENTS AND METHODS OF USE THEREOF

(A1) 20170183405: NOTCH1 RECEPTOR BINDING AGENTS AND METHODS OF USE THEREOF

GURNEY, AUSTIN L.

HOEY, TIMOTHY

BRUHNS, MAUREEN FITCH

AXELROD, FUMIKO TAKADA

ONCOMED PHARMACEUTICALS, INC.

41652/513

04-Jul-2016

(X0) 14550703: COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER

(A1) 20150183878: COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER

GURNEY, AUSTIN L.

SATO, AARON KEN

FITCH-BRUHNS, MAUREEN

ONCOMED PHARMACEUTICALS, INC.

39062/378

01-Jul-2016

(X0) 14693648: COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER

(A1) 20150337050: COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER

GURNEY, AUSTIN

SATO, AARON K.

ONCOMED PHARMACEUTICALS, INC.

39057/522

13-May-2016

(X0) 14572321: JAGGED-BINDING AGENTS AND USES THEREOF

(A1) 20150197561: JAGGED-BINDING AGENTS AND USES THEREOF

GURNEY, AUSTIN L.

HOEY, TIMOTHY CHARLES

SATO, AARON KEN

LAZETIC, ALEXANDRA

JI, ZHIMIN

ONCOMED PHARMACEUTICALS, INC.

38568/603